LANDMARK: Intralesional cidofovir for RRP

Article: Current use of intralesional cidofovir for recurrent respiratory papillomatosis

Derkay CS, Volsky PG, Rosen CA, et al. Current use of intralesional cidofovir for recurrent respiratory papillomatosis. Laryngoscope. 2013;123(3):705-12.

  • Survey of 82 surgeons managing adult and pediatric RRP
  • 18 consensus statements from the RRP task force
  • Intralesional cidofovir- use if debulking is needed every 2-3 months
  • Safe dosing of 3mg/kg
  • Need for special consent, discussion of off-label use and AKI in pediatric patients